This session of CVI Interventional Octagon webinar series is a Peripheral/Endovascular session on the topic of Extreme CLI and No-option Patients. Fellows and early-career physicians present their most interesting and challenging cases. The top cases were invited to present in a live webinar and a winner is chosen by the judging panel and receives a $500 prize. All finalists receive travel grants to CVI 2026 in Denver, CO, August 6-8, 2026.
Watch and claim credit below
Learning Objectives
- Learning Objectives:
- Discuss technical aspect of retrograde digital and pedal access
- Evaluate options for severely calcified arteries
- Evaluate clinical approaches, managing complications and trouble-shooting techniques in deep venous arterialization
- Recall post-op care, wound care, management and outcomes of the salvaged limb
Faculty
Jun Li, MD
University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH
Javier Vasquez, MD
Texas A&M University Medical Center, Baylor Scott & White Heart and Vascular Hospital, Dallas, TX
Subhash Banerjee, MD (moderator)
Baylor Heart and Vascular Hospital, Dallas, TX
Mehdi Shishehbor, DO, MPH, PhD (moderator)
Harrington Heart & Vascular Institute / University Hospitals, Cleveland, OH
The Finalists & Their Cases
Hector Elizondo Adamchick, MD, Baylor Scott and White, Dallas, TX – An option for “no-option” CLTI patients: Deep Venous Arterialization
Ekramul Gofer, MD, Miami Cardiac and Vascular Institute, Baptist Health – Persistent CLTI Despite Multiple Interventions
Gordon Wong, MD, University Hospitals Harrington Heart and Vascular Institute, Cleveland, OH – Acute Limb Ischemia Involving Occlusion of a Stented Femoropopliteal Bypass Graft
Ahmad Younes, MD, ProMedica – There Are Options!
This activity has been approved for AMA PRA Category 1.25 Credit™.
Claim CME Credit
1. View the webinar
2. At the end of the webinar, log onto: https://www.online-med-edu.com/cvi/102425/enduring/
3. Complete the Evaluation/Credit Request Form
4. Download or Print Credit Statement/Certificate
Interventional Octagon is made possible by generous grants from
Abbott, Boston Scientific Corporation, Cordis and Medtronic.
